This is a summary list of all resource providers at Xavier University of Louisiana . The list includes links to more detailed information, which may also be found using the eagle-i search app.
Core purpose: "To propagate, expand and supply high quality samples of normal mesenchymal stem cells (MSCs) from in vitro cultures with appropriate quality control assurances for use by LCRC investigators who are studying any aspect of MSCs in relationship to cancer."
To provide the best husbandry and environment for housing, maintaining, and caring for research and laboratory animals used at Xavier University, with in all applicable guidelines, and to assist users by providing information and support for handling and care of animals.
The Louisiana Cancer Research Consortium (LCRC) Tissue Procurement and Biospecimen Core Facility (TPBCF) is a part of the infrastructure to support the conduct of basic and clinical research for members of the LCRC. The goal of the repository is to support LCRC programmatic research in order to further improve our understanding of those molecular factors that contribute to cancer and that may lead to prevention, early detection, and cure.
The mission of the Biospecimen Core is to collect high quality samples of normal and diseased human material (e.g., whole blood, cellular blood components, plasma, urine, body fluids, DNA, and tumor tissue and cells) with appropriate clinical data and to make this material available to qualified researchers at Louisiana Cancer Research Consortium while ensuring the informed consent, safety, donor anonymity, and all regulatory safeguards are in place.
The Cell Analysis & Immunology Core Facility is a customer oriented service dedicated to supporting the research needs of the investigators of the Louisiana Cancer Research Consortium (LCRC). It provides state-of-art instrumentation and expertise for addressing experimental issues related to single cells, nuclei and chromosomes.
In addition to instrumentation, the Facility intends to collaborate with the investigators and contribute to all aspects of the research process. This includes consultation in experimental design, technical assistance in the operation of instruments, trouble shooting, data analysis and storage, interpretation of results and preparation and production of presentation graphics. The Facility is also communicating with investigators in other institutions and is devoted to introducing and developing new applications on our flow cytometers. In this way, investigators are provided with unlimited possibilities to answer questions regarding nature and function of cells by flow cytometry.
The center is focused on understanding and overcoming barriers to efficient oral, colonic, parenteral, pulmonary and vaginal delivery of drugs in the hopes of developing new treatments for chronic diseases such as cancer. Numerous new technologies are coming out of the Center as relationships have been formed with small, advanced technology businesses.
Our vision is to be the premier institution preparing pharmacy practitioners who demonstrate outstanding leadership and dedication to the medically underserved populations in our society, while striving to eliminate healthcare disparities. While the College of Pharmacy has played a major role in educating African American pharmacists, it has been integral in educating a diverse student population and remains committed to achieving excellence in all of its endeavors.
The mission of the College of Pharmacy is to prepare pharmacists to impact medically underserved communities, particularly African Americans, in an effort to eliminate health disparities through patient-centered care, community service and scholarly work. This mission is complementary to the university’s mission of “promoting a more just and humane society.” The College is committed to preparing all students for the broad range of careers in pharmacy by building a strong knowledge base in theory and practice, promoting critical thinking skills, and encouraging professional development and life-long learning.
The Cytoscape Consortium is an international group of open source developers that has futher developed Cytoscape originally created at the Institute of Systems Biology in Seattle in 2002.
"Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC."
The BiGCaT Bioinformatics group, the predecessor of the Department of Bioinformatics- BiGCaT, was born in 2001. It was a collaboration between the faculty of Biomedical Engineering at the Technische Universiteit Eindhoven, the Cardiovascular Research Institute Maastricht (CARIM) and the Nutrition and Toxicology Research Institute Maastricht (NUTRIM). The department is now embedded in the Faculty of Health Medicine and Life Sciences (FHML) and is one of the constituent departments of the NUTRIM School for Nutrition, Toxicology and Metabolism.
The Genomics Core Facility is a core resource of LSU Health Science Center, sponsored jointly by the Cancer Center and Genetics Center. The Facility is committed to providing quality service by fulfilling the needs of the research community in a consistently rapid, dependable, and economical fashion. Services include automated DNA sequencing, using state-of-the-art instrumentation (ABI PRISM 3130XL Genetic Analyzers) and the latest protocols to ensure high quality results at reseasonable prices. The Facility also houses an ABI Prism 7900 HT (a high through-put real-time PCR system) and a Biomek2000 liquid handling robot.
The J. Craig Venter Institute (JCVI, formerly The Institute for Genomic Research) has been awarded a contract from the National Institute of Allergy and Infectious Diseases to establish the Pathogen Functional Genomics Resource Center (PFGRC). The PFGRC provides scientists with centralized resources necessary to conduct functional genomics studies on a variety of pathogens for which genomic sequence information is currently, or will soon be, available. The Center supports five programs: DNA microarrays, the Invitrogen Gateway® Entry Clone Resource, Comparative Genomics, Proteomics, and Bioinformatics support. The near-term goals of the PFGRC are to provide microarray, genotyping, proteomics, clone access, bioinformatics, and repository support surrounded by a Center-Client web-based interface allowing access to resource acquisition, data, and data analysis.
LCRC Mission: To develop a coordinated cancer research and education program that will optimize discovery and development of innovative cancer therapies; lead to innovative clinical treatment programs offering new opportunities for early detection, treatment, and prevention of cancer in our region; and promote regional economic growth.
Xavier Mission within the LCRC: To develop a cancer research infrastructure at XU that will support current and future faculty; develop a new core, enhance research funding opportunities for faculty development and growth.
Louisiana Gene Therapy Research began operations in 2000 as a partnership among Louisiana's public and private health sciences centers including: Louisiana State University Health Sciences Centers in New Orleans and Shreveport, and Tulane University Health Sciences Center in New Orleans.
The Major Instrumentation Core has been established to provide technical services and consumable supplies necessary for the operation and maintenance of a variety of major instruments that support biomedical research at Xavier University. The long term goal of the Major Instrumentation Core is to enhance the overall biomedical research capabilities at Xavier University by making available essential instrument-based platforms for various research projects. To achieve this goal the Major Instrumentation Core has set the following specific aims:
1). support biomedical research projects on campus by providing essential analytical instrumentation,
2). maintain and operate existing instruments,
3). acquire new instruments, and
4). provide technical support for user community of the core.
Shared instrumentation facilities across Xavier University's research community
In December 2000, the LSUHSC Program in Gene Therapy in conjunction with the Louisiana Gene Therapy Research Consortium created the Microarray Core to cater to the growing needs of investigators who wanted to perform expression studies. Since that time, our core has helped researchers from around the world process over 3000 samples, resulting in numerous peer-reviewed scientific publications.
The purpose of this core laboratory is to assist investigators requiring detection, imaging, and morphometric analysis of gene and protein expression in any type of cell and tissue. Services, expertise and state-of -the-art biomedical imaging services will be provided with the hope of broadening and streamlining all morphological research.
The mission of Proteomics Core Facility is to help researchers advance their biomedical research programs. The Facility is equipped with gel electrophoresis units, image analyzers and digitizers, and robotics for mass spectrometry sample preparation. Currently, a Matrix-Assisted Laser Desorption/Ionization Mass Spectrometer instrument implements protein identification. The various applications include the studies of protein expression profile, posttranslational modifications, and partial sequencing of novel proteins. The staff also consult with researchers about their particular research interests and assist with the development of specific applications and solution to problems.
The RCMI Cell and Molecular Biology Core (CMB Core) provides focused services using cell and molecular biological techniques. It also provides access, upkeep and training on “state of the art” equipment. Funding by the RMCI allows these services to be offered at minimal cost to users of the core. Technical services and necessary consumable supplies are provided to support cancer research projects at Xavier University. The long term goal of the Cell and Molecular Biology Core is to enhance the overall biomedical research capabilities at Xavier University.
A Molecular Structure and Modeling Core laboratory has been established to provide technical services to support faculty researchers involved in cancer research and drug design at Xavier University. Drug design methods use molecular structure information and modeling methods to determine structure patterns among active and inactive compounds, identify and compare potential active sites, and screen databases to identify new leads. X-ray crystallography provides structure coordinates for druglike, organic compounds and small peptides. The goal of this core laboratory is to provide small molecule X-ray crystallographic services as well as to support ligand-based and structure-based drug design projects at any stage. The long term goal is to develop resources in order to enhance cancer related biomedical research capability at Xavier University. To achieve this goal, the Molecular Structure and Modeling Core Laboratory has set the following specific aims:
1. To provide salary support for a Core Scientist to provide molecular modeling services and training in support of Xavier faculty research projects
2. To establish new collaborations with faculty at other local and RCMI institutions who might benefit from molecular modeling services
3. To provide small molecule x-ray crystallography services
4. To provide support and maintenance costs for equipment in the MSM Core
The vision of the RCMI program is for Xavier University, in the next 5 to 7 years, to be seen nationally, not only for its eminence in graduating African American biologists, chemists, pre-med students and pharmacists, but also for its national prominence in research, particularly in the area of cancer research.
Xavier University of Louisiana is the only Catholic and historically Black university in the United States. Xavier's mission is to create a more just and humane society by preparing its students to assume roles of leadership and service through education.
The RCMI program at Xavier is focused on our strengths in research on cancer, an area where there are significant health disparities between African Americans and Caucasians. Building from these existing strengths, we have identified five specific goals for RCMI significantly increasing University-wide research capacity. The RCMI will:
•Enable Xavier to increase the number and quality of competitive researchers by hiring mid-career and early-career level faculty and assuring they have the tools and support needed to become successful.
•Enhance the competitiveness of strategically selected existing faculty and programs. This will have measurable outcomes including quality publications and successful grant proposals aimed at mainstream funding opportunities.
•Provide additional research cores and services thereby expanding and enhancing access to critical resources that will lead to greater success of faculty research programs.
•Enable enhanced administrative services to assure research support activities meet faculty needs, provide new incentives and assure federal compliance requirements are met with minimal additional burdens being placed on faculty.
•Support selected pilot projects that will assist investigators who are at the “cusp” of becoming fully competitive, allowing them to take their research projects to a new level.
Xavier's RCMI funding is provided by the NIH through the NCRR. The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), provides laboratory scientists and clinical researchers with the tools and training they need to understand, detect, treat and prevent a wide range of diseases. NCRR supports all aspects of clinical and translational research, connecting researchers, patients and communities across the nation. This support enables discoveries made at a molecular and cellular level to move to animal-based studies, and then to patient-oriented clinical research, ultimately leading to improved patient care. Through programs such as the Clinical and Translational Science Awards, NCRR convenes innovative research teams and equips them with essential tools and critical resources needed to tackle the nation's complex health problems.
Found 22 resource providers .